LUDOVINI, VIENNA
LUDOVINI, VIENNA
A machine learning approach applied to Reverse Phase Protein Microarray data for pathways activation mapping of KRAS wild type and mutated adenocarcinomas of the lung
2015 Bianconi, Fortunato; Baldelli, Elisa; Patiti, Federico; Valigi, Paolo; Haura, Eric B.; Crinò, Lucio; Ludovini, Vienna; Petricoin, Emanuel; Pierobon, Mariaelena
Antigen-Presenting Signaling Events in the Tumor Ecology Associate with Response to Anti-PD-1 Treatment in Lung Cancer
2019 Baldelli, Elisa; Hodge, K. Alex; Campbell, Michael J.; Bellezza, Guido; Demsko, Perry; Ludovini, Vienna; Sidoni, Angelo; Vandenberg, Scott; Bolen, Jennifer; Mandarano, Martina; Shah, Neil; Blackburn, Mattew; Liotta, Lance; Crino', Lucio; Giaccone, Giuseppe; Petricoin III, Emanuel F.; Pierobon, Mariaelena
Assessment of TILs, IDO-1 and PD-L1 in resected non small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications.
2018 Mandarano, M; Bellezza, G; Belladonna, Ml; Van den Eynde, Bj; Chiari, R; Vannucci, J; Mondanelli, G; Ludovini, V; Ferri, I; Bianconi, F; Del Sordo, R; Cagini, L; Albini, E; Metro, G; Puma, F; Sidoni, A
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications
2019 Mandarano, Martina; Bellezza, Guido; Belladonna, Maria Laura; J Van den Eynde, Benoit; Chiari, Rita; Vannucci, Jacopo; Mondanelli, Giada; Ludovini, Vienna; Ferri, Ivana; Bianconi, Fortunato; DEL SORDO, Rachele; Cagini, Lucio; Albini, Elisa; Metro, Giulio; Puma, Francesco; Sidoni, Angelo
Clinical outcomes to pemetrexed-based versus non-pemetrexed-based platinum doublets in patients with KRAS-mutant advanced non-squamous non-small cell lung cancer
2020 Ricciuti, B.; Brambilla, M.; Cortellini, A.; De Giglio, A.; Ficorella, C.; Sidoni, A.; Bellezza, G.; Crino, L.; Ludovini, V.; Baglivo, S.; Metro, G.; Chiari, R.
Detection of egfr mutations in plasma cell-free tumor dna of tki-treated advanced-nsclc patients by three methodologies: Scorpion-arms, pnaclamp, and digital pcr
2020 Siggillino, A.; Ulivi, P.; Pasini, L.; Reda, M. S.; Chiadini, E.; Tofanetti, F. R.; Baglivo, S.; Metro, G.; Crino, L.; Delmonte, A.; Minotti, V.; Roila, F.; Ludovini, V.
Dynamic network topologies analysis in proteomics data of NSCLC cell lines using a new pipeline based on machine learning tools
2018 Antonini, Chiara; Tomassoni, Lorenzo; Baldelli, Elisa; Ludovini, Vienna; Baglivo, Sara; Pierobon, Mariaelena; Petricoin, Emanuel F; Crinò, Lucio; Valigi, Paolo; Bianconi, Fortunato
Higher tlr7 gene expression predicts poor clinical outcome in advanced nsclc patients treated with immunotherapy
2021 Baglivo, S.; Bianconi, F.; Metro, G.; Gili, A.; Tofanetti, F. R.; Bellezza, G.; Ricciuti, B.; Mandarano, M.; Teti, V.; Siggillino, A.; Reda, M. S.; Chiari, R.; Pistola, L.; Sidoni, A.; Minotti, V.; Roila, F.; Ludovini, V.
Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy
2017 Ludovini, Vienna; Antognelli, Cinzia; Rulli, Antonio; Foglietta, Jennifer; Pistola, Lorenza; Eliana, Rulli; Floriani, Irene; Nocentini, Giuseppe; Tofanetti, Francesca Romana; Piattoni, Simonetta; Minenza, Elisa; Talesa, Vincenzo Nicola; Sidoni, Angelo; Tonato, Maurizio; Crinã², Lucio; Gori, Stefania
INSL4 as prognostic marker for proliferation and invasiveness in non-small-cell lung cancer
2021 Scopetti, D.; Piobbico, D.; Brunacci, C.; Pieroni, S.; Bellezza, G.; Castelli, M.; Ludovini, V.; Tofanetti, F. R.; Cagini, L.; Sidoni, A.; Puxeddu, E.; Della-Fazia, M. A.; Servillo, G.
Large Cell Neuroendocrine Carcinoma Transformation and EGFR-T790M Mutation as Coexisting Mechanisms of Acquired Resistance to EGFR-TKIs in Lung Cancer
2017 Baglivo, Sara; Ludovini, Vienna; Sidoni, Angelo; Metro, Giulio; Ricciuti, Biagio; Siggillino, Annamaria; Rebonato, Alberto; Messina, Salvatore; Crinò, Lucio; Chiari, Rita
Liquid Biopsy in early Breast Cancer: A preliminary Report
2020 Rulli, Antonio; Antognelli, Cinzia; Siggillino, Annamaria; Zayik, Svitlana; Izzo, Luciano; Covarelli, Piero; Talesa, Vincenzo Nicola; Ludovini, Vienna
Lorlatinib beyond progression plus platinum/pemetrexed for ALK-positive non-small cell lung cancer patients: report of two cases
2023 Metro, Giulio; Baglivo, Sara; Metelli, Niccolò; Bonaiti, Angelo; Matocci, Roberta; Di Girolamo, Bruna; Mandarano, Martina; Colafigli, Claudia; Bellezza, Guido; Roila, Fausto; Ludovini, Vienna
Modified gene expression of alveolar-capillar membrane, extracellular matrix and membrane proteins after induction chemotherapy for Non-Small Cell Lung Cancer
2016 Cagini, Lucio; Marinucci, Lorella; Ludovini, Vienna; Andolfi, M.; Potenza, R.; Balloni, Stefania; Vannucci, Jacopo; Siggillino, Annamaria; Tofanetti, F. R.; Bellezza, Guido; Bodo, Maria; Puma, Francesco
Pathway Activation Mapping of Kras Wild Type and Mutated Adenocarcinomas of the Lung: New Implications For Patient Stratification For Map Kinase Pathway Inhibition
2013 Baldelli, E; Haura, Eb; Crino', Lucio; Cress, W. D; Ludovini, Vienna; Schabath, M. B; Bellezza, Guido; Vannucci, Jacopo; Tassi, V; Pistola, L; Tofanetti, Fr; Flacco, A; Siggillino, Annamaria; Liotta, La; Petricoin, Ef; Pierobon, M.
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients
2015 D'Incecco, A; Andreozzi, M; Ludovini, Vienna; Rossi, E; Capodanno, A; Landi, L; Tibaldi, C; Minuti, G; Salvini, J; Coppi, E; Chella, A; Fontanini, G; Filice, M. E; Tornillo, L; Incensati, R. M; Sani, S; Crino', Lucio; Terracciano, L; Cappuzzo, F.
PD-L1 quantification across tumor types using the reverse phase protein microarray: Implications for precision medicine
2021 Baldelli, E.; Hodge, K. A.; Bellezza, G.; Shah, N. J.; Gambara, G.; Sidoni, A.; Mandarano, M.; Ruhunusiri, C.; Dunetz, B.; Abu-Khalaf, M.; Wulfkuhle, J.; Gallagher, R. I.; Liotta, L.; De Bono, J.; Mehra, N.; Riisnaes, R.; Ravaggi, A.; Odicino, F.; Sereni, M. I.; Blackburn, M.; Zupa, A.; Improta, G.; Demsko, P.; Crino', L.; Ludovini, V.; Giaccone, G.; Petricoin, E. F.; Pierobon, M.
Prevalence and spectrum of brca germline variants in central Italian high risk or familial breast/ovarian cancer patients: A monocentric study
2020 Foglietta, J.; Ludovini, V.; Bianconi, F.; Pistola, L.; Reda, M. S.; Al-Refaie, A.; Tofanetti, F. R.; Mosconi, A.; Minenza, E.; Anastasi, P.; Molica, C.; Stracci, F.; Roila, F.
Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer
2014 Bria, E; Modugno, F. D; Sperduti, I; Iapicca, P; Visca, P; Alessandrini, G; Antoniani, B; Pilotto, S; Ludovini, Vienna; Vannucci, Jacopo; Bellezza, Guido; Sidoni, Angelo; Tortora, G; Radisky, D. C; Crino', Lucio; Cognetti, F; Facciolo, F; Mottolese, M; Milella, M; Nistico, P.
Prognostic implication of aquaporin 1 overexpression in resected lung adenocarcinoma
2017 Bellezza, Guido; Vannucci, Jacopo; Bianconi, Fortunato; Metro, Giulio; Del Sordo, Rachele; Andolfi, Marco; Ferri, Ivana; Siccu, Paola; Ludovini, Vienna; Puma, Francesco; Sidoni, Angelo; Cagini, Lucio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A machine learning approach applied to Reverse Phase Protein Microarray data for pathways activation mapping of KRAS wild type and mutated adenocarcinomas of the lung | 2015 | Bianconi, Fortunato; Baldelli, Elisa; Patiti, Federico; Valigi, Paolo; Haura, Eric B.; Crinò, Lucio; Ludovini, Vienna; Petricoin, Emanuel; Pierobon, Mariaelena | |
| Antigen-Presenting Signaling Events in the Tumor Ecology Associate with Response to Anti-PD-1 Treatment in Lung Cancer | 2019 | Baldelli, Elisa; Hodge, K. Alex; Campbell, Michael J.; Bellezza, Guido; Demsko, Perry; Ludovini, Vienna; Sidoni, Angelo; Vandenberg, Scott; Bolen, Jennifer; Mandarano, Martina; Shah, Neil; Blackburn, Mattew; Liotta, Lance; Crino', Lucio; Giaccone, Giuseppe; Petricoin III, Emanuel F.; Pierobon, Mariaelena | |
| Assessment of TILs, IDO-1 and PD-L1 in resected non small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications. | 2018 | Mandarano, M; Bellezza, G; Belladonna, Ml; Van den Eynde, Bj; Chiari, R; Vannucci, J; Mondanelli, G; Ludovini, V; Ferri, I; Bianconi, F; Del Sordo, R; Cagini, L; Albini, E; Metro, G; Puma, F; Sidoni, A | |
| Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications | 2019 | Mandarano, Martina; Bellezza, Guido; Belladonna, Maria Laura; J Van den Eynde, Benoit; Chiari, Rita; Vannucci, Jacopo; Mondanelli, Giada; Ludovini, Vienna; Ferri, Ivana; Bianconi, Fortunato; DEL SORDO, Rachele; Cagini, Lucio; Albini, Elisa; Metro, Giulio; Puma, Francesco; Sidoni, Angelo | |
| Clinical outcomes to pemetrexed-based versus non-pemetrexed-based platinum doublets in patients with KRAS-mutant advanced non-squamous non-small cell lung cancer | 2020 | Ricciuti, B.; Brambilla, M.; Cortellini, A.; De Giglio, A.; Ficorella, C.; Sidoni, A.; Bellezza, G.; Crino, L.; Ludovini, V.; Baglivo, S.; Metro, G.; Chiari, R. | |
| Detection of egfr mutations in plasma cell-free tumor dna of tki-treated advanced-nsclc patients by three methodologies: Scorpion-arms, pnaclamp, and digital pcr | 2020 | Siggillino, A.; Ulivi, P.; Pasini, L.; Reda, M. S.; Chiadini, E.; Tofanetti, F. R.; Baglivo, S.; Metro, G.; Crino, L.; Delmonte, A.; Minotti, V.; Roila, F.; Ludovini, V. | |
| Dynamic network topologies analysis in proteomics data of NSCLC cell lines using a new pipeline based on machine learning tools | 2018 | Antonini, Chiara; Tomassoni, Lorenzo; Baldelli, Elisa; Ludovini, Vienna; Baglivo, Sara; Pierobon, Mariaelena; Petricoin, Emanuel F; Crinò, Lucio; Valigi, Paolo; Bianconi, Fortunato | |
| Higher tlr7 gene expression predicts poor clinical outcome in advanced nsclc patients treated with immunotherapy | 2021 | Baglivo, S.; Bianconi, F.; Metro, G.; Gili, A.; Tofanetti, F. R.; Bellezza, G.; Ricciuti, B.; Mandarano, M.; Teti, V.; Siggillino, A.; Reda, M. S.; Chiari, R.; Pistola, L.; Sidoni, A.; Minotti, V.; Roila, F.; Ludovini, V. | |
| Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy | 2017 | Ludovini, Vienna; Antognelli, Cinzia; Rulli, Antonio; Foglietta, Jennifer; Pistola, Lorenza; Eliana, Rulli; Floriani, Irene; Nocentini, Giuseppe; Tofanetti, Francesca Romana; Piattoni, Simonetta; Minenza, Elisa; Talesa, Vincenzo Nicola; Sidoni, Angelo; Tonato, Maurizio; Crinã², Lucio; Gori, Stefania | |
| INSL4 as prognostic marker for proliferation and invasiveness in non-small-cell lung cancer | 2021 | Scopetti, D.; Piobbico, D.; Brunacci, C.; Pieroni, S.; Bellezza, G.; Castelli, M.; Ludovini, V.; Tofanetti, F. R.; Cagini, L.; Sidoni, A.; Puxeddu, E.; Della-Fazia, M. A.; Servillo, G. | |
| Large Cell Neuroendocrine Carcinoma Transformation and EGFR-T790M Mutation as Coexisting Mechanisms of Acquired Resistance to EGFR-TKIs in Lung Cancer | 2017 | Baglivo, Sara; Ludovini, Vienna; Sidoni, Angelo; Metro, Giulio; Ricciuti, Biagio; Siggillino, Annamaria; Rebonato, Alberto; Messina, Salvatore; Crinò, Lucio; Chiari, Rita | |
| Liquid Biopsy in early Breast Cancer: A preliminary Report | 2020 | Rulli, Antonio; Antognelli, Cinzia; Siggillino, Annamaria; Zayik, Svitlana; Izzo, Luciano; Covarelli, Piero; Talesa, Vincenzo Nicola; Ludovini, Vienna | |
| Lorlatinib beyond progression plus platinum/pemetrexed for ALK-positive non-small cell lung cancer patients: report of two cases | 2023 | Metro, Giulio; Baglivo, Sara; Metelli, Niccolò; Bonaiti, Angelo; Matocci, Roberta; Di Girolamo, Bruna; Mandarano, Martina; Colafigli, Claudia; Bellezza, Guido; Roila, Fausto; Ludovini, Vienna | |
| Modified gene expression of alveolar-capillar membrane, extracellular matrix and membrane proteins after induction chemotherapy for Non-Small Cell Lung Cancer | 2016 | Cagini, Lucio; Marinucci, Lorella; Ludovini, Vienna; Andolfi, M.; Potenza, R.; Balloni, Stefania; Vannucci, Jacopo; Siggillino, Annamaria; Tofanetti, F. R.; Bellezza, Guido; Bodo, Maria; Puma, Francesco | |
| Pathway Activation Mapping of Kras Wild Type and Mutated Adenocarcinomas of the Lung: New Implications For Patient Stratification For Map Kinase Pathway Inhibition | 2013 | Baldelli, E; Haura, Eb; Crino', Lucio; Cress, W. D; Ludovini, Vienna; Schabath, M. B; Bellezza, Guido; Vannucci, Jacopo; Tassi, V; Pistola, L; Tofanetti, Fr; Flacco, A; Siggillino, Annamaria; Liotta, La; Petricoin, Ef; Pierobon, M. | |
| PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients | 2015 | D'Incecco, A; Andreozzi, M; Ludovini, Vienna; Rossi, E; Capodanno, A; Landi, L; Tibaldi, C; Minuti, G; Salvini, J; Coppi, E; Chella, A; Fontanini, G; Filice, M. E; Tornillo, L; Incensati, R. M; Sani, S; Crino', Lucio; Terracciano, L; Cappuzzo, F. | |
| PD-L1 quantification across tumor types using the reverse phase protein microarray: Implications for precision medicine | 2021 | Baldelli, E.; Hodge, K. A.; Bellezza, G.; Shah, N. J.; Gambara, G.; Sidoni, A.; Mandarano, M.; Ruhunusiri, C.; Dunetz, B.; Abu-Khalaf, M.; Wulfkuhle, J.; Gallagher, R. I.; Liotta, L.; De Bono, J.; Mehra, N.; Riisnaes, R.; Ravaggi, A.; Odicino, F.; Sereni, M. I.; Blackburn, M.; Zupa, A.; Improta, G.; Demsko, P.; Crino', L.; Ludovini, V.; Giaccone, G.; Petricoin, E. F.; Pierobon, M. | |
| Prevalence and spectrum of brca germline variants in central Italian high risk or familial breast/ovarian cancer patients: A monocentric study | 2020 | Foglietta, J.; Ludovini, V.; Bianconi, F.; Pistola, L.; Reda, M. S.; Al-Refaie, A.; Tofanetti, F. R.; Mosconi, A.; Minenza, E.; Anastasi, P.; Molica, C.; Stracci, F.; Roila, F. | |
| Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer | 2014 | Bria, E; Modugno, F. D; Sperduti, I; Iapicca, P; Visca, P; Alessandrini, G; Antoniani, B; Pilotto, S; Ludovini, Vienna; Vannucci, Jacopo; Bellezza, Guido; Sidoni, Angelo; Tortora, G; Radisky, D. C; Crino', Lucio; Cognetti, F; Facciolo, F; Mottolese, M; Milella, M; Nistico, P. | |
| Prognostic implication of aquaporin 1 overexpression in resected lung adenocarcinoma | 2017 | Bellezza, Guido; Vannucci, Jacopo; Bianconi, Fortunato; Metro, Giulio; Del Sordo, Rachele; Andolfi, Marco; Ferri, Ivana; Siccu, Paola; Ludovini, Vienna; Puma, Francesco; Sidoni, Angelo; Cagini, Lucio |